Blueprint
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of
1934
March
1, 2019
Date of Report
(Date of earliest event reported)
|
SANUWAVE HEALTH, INC.
|
|
(Exact
name of registrant as specified in its charter)
|
|
Nevada
|
000-52985
|
20-1176000
|
|
(State or other
jurisdiction of
incorporation)
|
(Commission File
Number)
|
(IRS
Employer Identification
No.)
|
3360
Martin Farm Road, Suite 100, Suwanee, Georgia
(Address of
principal executive offices)
30024
(Zip
Code)
(770)
419-7525
Registrant’s
telephone number, including area code
|
N/A
|
|
(Former
name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registration is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 or
Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging
growth company. ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item 1.01. Entry into a Material Definitive
Agreement.
On
March 1, 2019, SANUWAVE Health, Inc. (the “Company”)
amended the expiration date of the Class N Warrants and Class O
Warrants (the “Warrant Extension”), from March 17,
2019, to June 28, 2019, to be effective on March 1, 2019. The
Company sent a letter to the holders of the Class N Warrants and
Class O Warrants regarding the Warrant Extension on March 14, 2019
(the “Warrant Extension Letter”). Certain of the Class
O Warrants are held by Kevin Richardson, John Nemelka, Alan Rubino,
Michael Stolarski, and Maj-Britt Kaltoft, all of whom are members
of our Board of Directors. Certain of the Class O Warrants are held
by Lisa Sundstrom, Controller and Chief Financial Officer of the
Company.
The
foregoing is only a brief description of the Warrant Extension
Letter, does not purport to be a complete description of the rights
and obligations of the parties thereunder and is qualified in its
entirety by reference to the full text of the Warrant Extension
Letter taken together with the form of Class N Warrant and form of
Class O Warrant. The form of the Class N Warrant is filed as
Exhibit 4.1 to the Company’s Current Report on Form 8-K filed
with the SEC on November 9, 2017, the form of the Class O Warrant
is filed as Exhibit 4.1 to this Current Report on Form 8-K filed
and the Warrant Extension Letter is filed as Exhibit 4.2 to this
Current Report on Form 8-K, and each is incorporated herein by
reference.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
Exhibit
No.
Description
Letter to Class N
Warrant holders and Class O Warrant holders, dated March 14,
2019.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
SANUWAVE HEALTH, INC.
|
|
|
Date:
March 15, 2019
|
By:
|
/s/
Lisa E.
Sundstrom
|
|
|
|
|
Lisa E.
Sundstrom
|
|
|
|
|
Controller
and Chief Financial Officer
|
|